Submission of Un-Audited financial results of the Company for the quarter and Nine months ended 31st December, 2025
Awaiting price reaction for this filing.
TMT India Ltd filed its un-audited standalone results for Q3 FY26 and the nine months ended 31 December 2025. The company reported zero revenue from operations across all periods under review, with only ₹3.01 lakhs of 'other income' in Q3 FY26 versus nil in earlier quarters. Total expenses were ₹6.89 lakhs in Q3, producing a loss before tax of ₹3.88 lakhs (improved from a ₹6.99 lakh loss a year ago). For the nine months, the loss narrowed to ₹15.16 lakhs from ₹21.66 lakhs, and the full-year FY25 loss stood at ₹45.98 lakhs. Basic and diluted EPS was -₹0.08 for Q3. The statutory auditor (a sole proprietor firm) issued a clean, unqualified limited review report. A notable disclosure states that 50,000 equity shares held in Sree Rayalaseema Alkalies & Allied Chemicals were illegally transferred by a third party, with the matter being pursued in legal forums.
The company has no operating revenue and is entirely dependent on incidental other income while continuing to post losses, raising significant going-concern concerns for shareholders. A modest narrowing of losses is driven by expense cuts rather than any income recovery, signalling no near-term operational turnaround.